Deaths of Despair’ on the Rise in U.S

https://www.medpagetoday.com/blogs/themethodsman/71730

A startling surge in deaths due to alcohol, drug abuse, and suicide has caught the U.S. off guard. In the most detailed study yet, appearing in JAMA, researchers from the University of Washington highlight where the problem is the worst. In this 150-Second Analysis, F. Perry Wilson, MD, discusses the study and the implications of “deaths of despair.”

Death due to alcohol, drugs, suicide, and interpersonal violence – sometimes characterized as “deaths of despair” are on the rise in the U.S., particularly among white males, reversing a centuries-long improvement in life expectancy.

But these deaths are not distributed evenly around the country. In a new analysis appearing in the Journal of the American Medical Association, researchers from the University of Washington used county level data to characterize the extent, and variation, of deaths from these causes.

The study of variation in medicine is more important than it seems at first blush. High levels of geographic variation in a disease or a treatment strategy suggest that potentially modifiable factors are at play. Put it this way, if I told you that the rate of cholangiocarcinoma was fairly evenly distributed throughout the country, you might conclude that what we’re seeing is more or less a baseline rate, something stochastic, where only really broad changes in diagnosis or treatment will make an impact.

What this study shows us, is that these “deaths of despair” are by no means uniform. In fact, variation is highly pronounced and dramatic.

Let’s look at the rate of deaths associated with drug use nationwide in 2014.

You see a 58-fold range in the death rate from the lowest to the highest counties, with West Virginia and Kentucky particular hot spots.

Looking at the change in death rate from 1980 to 2014 provides a window into the scale of this epidemic.

 

 

 

 

 

 

 

 

 

Deaths due to drug use did not decline over these two and a half decades in a single county in the United States. Not one. And the rate in those hot spot areas has increased fifty-fold.

Moreover, the extent of variation from county to county has increased dramatically. What this tells us is that these deaths are not due to some baseline physiology, but rather to local factors. Lead author Dr. Laura Dwyer-Lindgren told me she wasn’t comfortable with the “deaths of despair label,” as they don’t really know what’s driving these changes.

“A lot of the discourse around the just massive increase in deaths from drug use disorders is around the massive increase in deaths specifically from opioids and around how that relates to prescribing and availability.”

We actually have data on the rate of prescribing of opioids on a county level in the U.S., though not from Dr. Dwyer-Lindgren’s paper.

Here is a map from the CDC looking at opioid prescription rates. We’ll put it up next to the map documenting the increase in deaths from drug abuse.

 

 

Sometimes a picture is worth 1,000 statistical tests.

F. Perry Wilson, MD, MSCE, is an assistant professor of medicine at the Yale School of Medicine. He is a MedPage Today reviewer, and in addition to his video analyses, he authors a blog, The Methods Man. You can follow @methodsmanmd on Twitter.

10 Comments

 

 

cookie cutter medical care ?

One of the basics of the practice of medicine is the starting, changing, stopping a pt’s therapy.  Within the Controlled Substance Act.. it is specific that no prescriber may prescribe for a pt that they have not done a IN PERSON PHYSICAL EXAM… according to this letter is would appear that  Dr. Clarie Horn, MD is approving – or disapproving – controlled medications for pts in which she has only “REVIEWED” this pt’s medical records.

According to this https://www.vitals.com/doctors/Dr_Claire_Horn.html#! 

Dr Horn has offices in Indianapolis, IN and Dallas, TX… so apparently she is currently licensed in those two states. So unless she is making medical decisions on pts located in IN or TX… – unless she is licensed in other states – then she would be attempting to practice medicine in states in which she is not licensed.  Which is ILLEGAL …

These decisions by some physician employed by some insurance and/or PBM’s who are trying to practice medicine in areas and in means that they are not licensed to do. Perhaps pts who are beneficiaries of these insurance companies who they are attempting to practice medicine on… perhaps they should start filing complaints with medical license boards of the states these doctors are licensed in and the state in which the pt resides.

More of these corporations get by with what they are doing because no one challenges them… so like most corporations…  they will push the envelope as much as they can…  “laws are for the little people ” … until they are challenged and some agency tells then to cut the crap out.

Portugal’s Example: What Happened After It Decriminalized All Drugs, From Weed to Heroin

https://news.vice.com/article/ungass-portugal-what-happened-after-decriminalization-drugs-weed-to-heroin

As diplomats gather at the United Nations in New York this week to consider the future of global drug policy, one Portuguese official, João Goulão, will likely command attention that far outstrips his country’s influence in practically any other area. That’s because 16 years ago, Portugal took a leap and decriminalized the possession of all drugs — everything from marijuana to heroin. By most measures, the move has paid off.

Today, Portuguese authorities don’t arrest anyone found holding what’s considered less than a 10-day supply of an illicit drug — a gram of heroin, ecstasy, or amphetamine, two grams of cocaine, or 25 grams of cannabis. Instead, drug offenders receive a citation and are ordered to appear before so- called “dissuasion panels” made up of legal, social, and psychological experts. Most cases are simply suspended. Individuals who repeatedly come before the panels may be prescribed treatment, ranging from motivational counseling to opiate substitution therapy.

“We had a lot of criticism at first,” recalled Goulão, a physician specializing in addiction treatment whose work led Portugal to reform its drug laws in 2000, and who is today its national drug coordinator. After decriminalizing, the first inquiries Portugal received from the International Narcotics Control Board — the quasi-judicial UN oversight body established by the UN drug convention system — were sharp and scolding.

“Now things have changed completely,” he went on. “We are pointed to as an example of best practices inside the spirit of the conventions.” Indeed, Werner Sipp, the new head of the board, said as much at the UN’s Commission on Narcotic Drugs in Vienna earlier this year.

‘It was the combination of the law and these services that made it a success. It’s very difficult to find people in Portugal who disagree with this model.’

Though often narrowly assessed in reference to its decriminalization law, Portugal’s experience over the last decade and a half speaks as much to its free public health system, extensive treatment programs, and the hard to quantify trickle down effects of the legislation. In a society where drugs are less stigmatized, problem users are more likely to seek out care. Police, even if they suspect someone of using drugs, are less likely to bother them. Though at least 25 countries have introduced some form of decriminalization, Portugal’s holistic model and its use of dissuasion panels sets it apart.

The rate of new HIV infections in Portugal has fallen precipitously since 2001, the year its law took effect, declining from 1,016 cases to only 56 in 2012. Overdose deaths decreased from 80 the year that decriminalization was enacted to only 16 in 2012. In the US, by comparison, more than 14,000 people died in 2014 from prescription opioid overdoses alone. Portugal’s current drug-induced death rate, three per million residents, is more than five times lower than the European Union’s average of 17.3, according to EU figures.

Related: Here’s What to Expect at the Big Drug Meeting This Week at the UN

When Portugal decided to decriminalize in 2000, many skeptics assumed that the number of users would skyrocket. That did not happen. With some exceptions, including a marginal increase among adolescents, drug use has fallen over the past 15 years and now ebbs and flows within overall trends in Europe. Portuguese officials estimate that by the late 1990s roughly one percent of Portugal’s population, around 100,000 people, were heroin users.

Today, “we estimate that we have 50,000, most of them under substitution treatment,” said Goulão before adding that he’s recently seen a small uptick in use of the drug, predominantly among former addicts that got clean. This reflects Portugal’s tenuous economic condition, he contends.

“People use drugs for one of two reasons — either to potentiate pleasures or relieve unpleasure — and the types of drugs and the type of people who use drugs carries a lot according to the conditions of life in the country,” he remarked.

Parallel harm reduction measures, such as needle exchanges and opioid substitution therapy using drugs like methadone and buprenorphine, he said, serve as a cushion to prevent the spread of communicable diseases and a rise in overdoses even if the number of users injecting heroin happens to increase for a period of time.

“I think harm reduction is not giving up on people,” said Goulão. “I think it is respecting their timings and assuming that even if someone is still using drugs, that person deserves the investment of the state in order to have a better and longer life.”

Such statements, once considered radical, are becoming more appealing to drug officials in other countries. Decriminalization and harm reduction lends greater attention to the human rights of users while allowing law enforcement resources to be spent elsewhere. And though it’s a major shift, Portuguese decriminalization is not a revolution in terms of international law.

Drugs are still illegal in Portugal, drug dealers and traffickers are still sent to jail, and the country has carefully kept itself within the confines of the UN’s drug convention system that inform national drug laws. For decades the three treaties were seen as prescribing jail time for users, but experts have long contended — and governments now increasingly recognize — that they give countries wide latitude in how to treat and police users.

When Portugal decriminalized, UN member states were just years removed from a 1998 special session of the General Assembly that convened under the fanciful pretext of eliminating drug use worldwide. On Tuesday, member states adopted a new outcome document that is meant to reposition drug policy. It stops short of what many advocates would have liked, excluding the actual words “harm reduction” while failing to address the death penalty for drug offenders, which member states noted repeatedly on Tuesday. The document reflects both an evolution in drug policy in many parts of the world over the last two decades, but is also a testament to the continued influence of conservative countries that still favor interdiction.

Related: How Russia Became the New Global Leader in the War on Drugs

Goulão himself is skeptical of some aspects of marijuana reform in places like the United States, which he says can conflate medical use with recreational markets. “Sometimes I feel the promoters of this discussion are mixing things together using a lack of intellectual seriousness,” he said.

Though heroin use is often highlighted to show the efficacy of Portugal’s model, today most users that come before panels are in fact caught with either hashish or cannabis, said Nuno Capaz, a sociologist who serves on Lisbon’s dissuasion panel. Between 80 to 85 percent of all people who report to the panels are first-time offenders and deemed to be recreational users, meaning their cases are suspended.

For those who have been repeatedly caught or are identified as addicts, the panels can order sanctions or treatment. Recreational users may face fines or be ordered to provide community service. If an addict refuses treatment, they are required to check in regularly with their “family doctor” — the medical professional in the person’s locality that provides checkups and other services to them under Portugal’s free national healthcare program. Such a close, pre-existing relationship between medical professionals and Portuguese residents is another feature of the model, and one that could be hard to replicate in a country like the US.

“If the person doesn’t show up at the doctor, we ask the police to personally hand them a notification so they know they are supposed to be in a specific place,” said Capaz. “The important part is to maintain the connection to the treatment system.”

The role of police coordinating with health officials to ensure treatment demonstrates the altered relationship between them and drug users over the past decade and a half, and one that contrasts dramatically with how police orient themselves in countries like the US.

“This small change actually makes a huge change in terms of police officers’ work,” said Capaz, referring to decriminalization. “Of course every police officer knows where people hang out to smoke joints. If they wanted to they would just go there and pick up the same guy over and over. That doesn’t happen.”

Working in parallel to government efforts, non-profit groups play a role in providing clean needles and even distributing crack pipes as a way to entice drug users into the network of state service providers.

Ricardo Fuertes, project coordinator at GAT, an outreach organization founded by people living with HIV, works at one of the group’s drop-in centers, nestled in a residential building in Lisbon. The location, he says, is a sign of the decrease in stigma towards drug use.

“It’s very obvious that it’s a place for people who use drugs. It’s very open, but we don’t have complaints,” said Fuertes, referring to the drop-in center. “The general population even comes to get tests done. I think it shows this isn’t a ghetto service.”

But care and outreach providers and the people they help have felt the pinch of Portugal’s economic troubles. In 2011, the country was bailed out by the European Union and the IMF, and later passed austerity measures that imposed considerable cuts on public services.

Related: Here’s How Zero-Tolerance Drug Policies Have Damaged Public Health Worldwide

Goulão said that drug treatment programs have been relatively insulated, but funds for job programs that could help employers pay the wages of drug users were decreased. Fuertes went a bit further, saying that some providers have had to lower costs. He explained that government funding may be allocated only for a year at a time, making long-term planning difficult.

“It’s not easy for many people, and of course people who use drugs are not the exception,” he said. “We see many of our clients facing very difficult situations.”

Portuguese health workers refer to Greece as a cautionary tale. Wracked by a budgetary crisis and the austerity conditions of repeated bailouts, Greece experienced an explosion of HIV transmission rates after budget cuts left health programs drastically underfunded. According to EU figures, only Greece and Latvia experienced larger cuts than Portugal to its public health services between the period of 2005 to 2007 and 2009 to 2012.

And yet Portugal experienced no discernable rise in HIV transmission — the cushion effect in action.

“Usually the focus is on the decriminalization itself, but it worked because there were other services, and the coverage increased for needle replacement, detox, therapeutic communities, and employment options for people who use drugs,” said Fuertes. “It was the combination of the law and these services that made it a success. It’s very difficult to find people in Portugal who disagree with this model.”

In the run-up to the UN General Assembly’s special session, Goulão cautioned that countries had to consider their own domestic environments first in learning from Portugal’s experience.

“We don’t assume that this is the silver bullet, but in my view it has been very important because it introduced coherence into the whole system,” he said. “If our responses are based in the idea that we talking about addiction, that we are talking about chronic disease, talking about a health issue — to have it out of the penal system is a clear improvement. It was really important for our society because it allowed us to drop the stigma.”

Both Advil and Opiates are EQUALLY AS EFFECTIVE .. in getting – FAKE NEWS- media coverage

Does That JAMA Study Really Show That Advil Is Just As Effective As Opioids?

Since responses to pain treatment vary widely, it is hazardous to draw broad conclusions from a single study.

https://reason.com/blog/2018/03/09/does-that-jama-study-really-show-that-ad

According to Vox, a JAMA study published this week “finally” provides “proof” that “opioids are no better than other medications for some chronic pain.” The results of the study are “devastating,” Vox says. To whom or what is not exactly clear, but the author of the article, Julia Belluz, seems to see the study as conclusive evidence against the notion that “opioids help patients with chronic pain in the long run” or that “they are worth all that risk” of “addiction and death.” Similarly, NBC News declares that the “jury’s in,” and its verdict is that “opioids are not better than other medicines for chronic pain.” Mother Jones likewise says “a new study shows that opioids are no better than other meds for chronic pain,” while Newser agrees that Tylenol and Advil “work just as well as opioids.”

The JAMA study—the work of a team led by internist Erin Krebs, a researcher with the Minneapolis Veterans Affairs Health Care System—did not actually demonstrate any of that. But it did highlight journalists’ eagerness to believe that no one really needs narcotics for pain relief, which reflects the widespread desire for a simple solution to the “opioid epidemic.”

If opioids have no advantage over other analgesics, why prescribe them at all? Why risk “addiction and death” when over-the-counter pain relievers are just as effective? Even if we ignore the fact that the risks for pain patients are actually pretty small (and the fact that opioid-related deaths primarily involve illegally produced drugs), this study does not show what the headlines claim.

Krebs and her colleagues recruited 240 patients with moderate to severe chronic back pain or hip or knee osteoarthritis from V.A. primary care clinics and randomly assigned them to opioid or nonopioid treatment. The opioid group initially received immediate-release morphine, oxycodone, or hydrocodone plus acetaminophen. If those medications proved inadequate, subjects were treated with sustained-action morphine or oxycodone, followed by fentanyl patches if necessary. The nonopioid group initially received acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, followed if necessary by various other medications, including nortriptyline, amitriptyline, gabapentin, topical analgesics, pregabalin, duloxetine, and tramadol.

The main outcome measures were pain-related function (measured by a questionnaire, with higher scores indicating a bigger burden from pain) and pain intensity (also self-reported, on a scale of 0 to 10). After 12 months, both groups were significantly better off by those two measures. The mean pain-related function score fell from 5.4 to 3.4 in the opioid group and from 5.5 to 3.3 in the nonopioid group. Mean pain intensity fell from 5.4 to 4 in the opioid group and from 5.4 to 3.5 in the nonopioid group. The difference between the two groups was statistically significant only for pain intensity, and the researchers note that “the clinical importance of this finding is unclear,” since “the magnitude was small.”

In short, both groups fared about the same. “Treatment with opioids was not superior to treatment with nonopioid medications for improving pain-related function over 12 months,” Krebs et al. conclude. “Results do not support initiation of opioid therapy for moderate to severe chronic back pain or hip or knee osteoarthritis pain.”

People in pain vary widely in how they respond to medication, so the fact that opioids did not have an advantage, on average, for this particular sample with these particular types of pain does not mean they are not a better choice for some patients. The study sample was 87 percent male, and it was drawn from V.A. clinics, which may not be representative of the general patient population. The conditions were limited to chronic back pain and chronic hip or knee pain caused by osteoarthritis, so the study does not speak to opioid treatment for other kinds of pain. The initial pain intensities were middling, so the study may not reflect the experiences of patients with more severe pain.

Notably, the researchers excluded patients who were on long-term opioid therapy, which means they ignored people who had already found they did not get adequate relief from other treatments. It seems reasonable to assume that people who are currently using opioids to treat chronic pain are doing so because they think these drugs work better for them than Advil or Tylenol, and they may even be right to think that. If you exclude those patients from a study of pain treatment, you are excluding precisely the people who are most likely to get more relief from opioids.

The bottom line is that patients should be able to get the medications that work best for them. Many people with severe chronic pain report going through a long list of alternative treatments before finding that opioids were the only thing that kept the agony at bay and gave them a decent quality of life. A study like this one is utterly irrelevant to people in that situation, and to suggest otherwise is illogical as well as cruel.

Addendum: Krebs notes that the study included patients who had tried opioids or who were using them intermittently, provided they were taking fewer than 60 short-acting tablets per month. “To be eligible for the study, we required patients to have moderate-severe pain despite analgesic use,” she writes in an email. “All patients in the study had tried and failed other analgesics….We excluded people with more frequent opioid use because they would need tapering/discontinuation of opioids if randomized to the nonopioid arm. Long-term opioid use causes physiological dependence (a phenomenon distinct from addiction), which generates additional clinical complexity.”

I want to hear from you

Hi Steve –

Did you know that the ACLU has sued every president since our founding nearly 100 years ago? Every single president – from both of our two major political parties. No matter who’s in charge, we know our job is to defend the Constitution.

The ACLU is a nonpartisan organization, and we believe civil rights and liberties shouldn’t be partisan issues. These fundamental freedoms guaranteed by our Constitution transcend party lines.

That’s why it’s crucial that all of us stay active this year. We have to do everything we can to stop Donald Trump’s extraordinary assault on the Constitution and his reckless efforts to trample on people’s rights. That means using every bit of influence we can muster to influence decisions that affect the future of civil liberties.

Wherever you fall on the political spectrum, you have an important role to play to uphold our American values. Please take this short survey so we can identify activism opportunities for you to make the biggest impact.

There have always been conservatives and progressives among the ranks of the ACLU. Democrats, Republicans, Libertarians, Socialists – the banner of civil liberties is big enough to cover all of us.

We’ve been vocal in our opposition to the Trump administration’s policies – as we have been with every previous administration. But things are different now. This administration’s behavior isn’t normal by any definition.

That’s why we plan to engage in nonpartisan issue advocacy around the 2018 elections. We want all candidates to respect the rights and liberties of everyone in this country – and we know ACLU supporters will demand no less. We’ll work with supporters like you to ensure that all voters have the information they need to evaluate candidates’ positions on the key civil rights and liberties issues of our time.

We want to make sure we’re giving you the most relevant and meaningful opportunities to get involved. Will you take this quick survey to tell us about yourself?

If you’ve chipped in to an elected representative before, our advocates might enlist you to contact them on a key vote protecting our fundamental freedoms. Or if members of your political party are putting a core value of yours on the line, we might ask you to step up and make your voice heard.

The more you share in this short survey, the easier it will be for our advocates and organizers to match you up with opportunities to defend and protect civil liberties. We won’t ask more of you than you can manage – but we will ask you to step up in meaningful ways. That’s part of what it means to be an ACLU supporter in such an unprecedented time.

Thanks for fighting for our values,

Anthony D. Romero
ACLU Executive Director

 

institutions are ignoring the law in order to get the execution drugs they need to carry out the death penalty

ACLU: Nebraska Illegally Obtaining and Storing Execution Drugs

https://www.newsmax.com/newsfront/aclu-nebraska-execution-drugs-fentanyl/2018/03/12/id/848168/

The state of Nebraska has been breaking federal law to obtain and store an experimental drug cocktail used in lethal injections, the American Civil Liberties Union alleges in a complaint filed Monday.

The ACLU of Nebraska, along with the DEA, has filed a complaint which claims that Nebraska unlawfully obtained fentanyl, a Schedule II controlled substance, in order to execute prisoners Jose Sandoval and Carey Moore, arguing that the DEA ought to seize the drugs before they are used.

 “As the complaint shows, a person or entity, including government agencies, needs a DEA registration to import a controlled substance,” wrote Danielle Conrad, ACLU of Nebraska executive director, on Monday. “Federal law also requires those that handle a controlled substance to have a DEA registration particular to their authorized usage. These laws apply to the Nebraska Department of Corrections and to the Nebraska State Penitentiary (NSP), where the state carries out executions. But both institutions are ignoring the law in order to get the execution drugs they need to carry out the death penalty.”
 The ACLU notes that the NSP applied to register as a DEA importer in multiple years with a false pharmacy license number, one registered to a pharmacy that the Department of Corrections operates four miles away despite the license being specific to the pharmacy’s address and the people listed in the application.

“Put simply, the state broke the federal law by applying for an import registration for the prison based on the false claim that the prison possessed a state pharmacy license it did not,” Conrad continued. “That licensed was assigned to the state pharmacy, and Nebraska law forbids it from being assigned, borrowed, or used by some other person or entity. In fact, in 2011, the pharmacy itself used this very same license number to apply legally for its own DEA import registration. When the NSP did the same, it was illegal.”

Jose Sandoval  After he was sent to death row, Sandoval pleaded guilty to two additional murders in the months leading up to the bank slayings  http://www.omaha.com/townnews/criminal_law/jose-sandoval-argues-he-was-illegally-sentenced-to-death-when/article_61c613a0-db7d-11e7-b3c9-ff2e1dad2bfd.html

Carey Moore Moore shot and killed Omaha cab drivers Reuel Van Ness and Maynard Helgeland in the summer of 1979.  http://www.omaha.com/news/nebraska/nebraska-notifies-death-row-inmate-carey-dean-moore-of-drugs/article_1e5f1c5c-fd5a-11e7-9b15-773ca0854563.html

The notice provided Friday to Moore said the state intends to use a series of four drugs — in order: diazepam, fentanyl citrate, cisatracurium besylate and potassium chloride — to carry out the execution.

Doesn’t it just give you the “warm fuzzies” to know that the ACLU is defending the rights of murders to not be executed by  FDA APPROVED drugs.

The DEA has plainly stated that the use of a opiate and a benzo can be FATAL… throw in a paralytic agent (stop breathing) and Pot Cl to stop the heart from beating.. should work !    Where are they in defending the rights of chronic pain pts to have access to medically necessary medications ?  I forgot, the 8th Amendment – cruel and unusual punishing – only applies to PRISONERS …

US justice (DOJ) dismissed my inquiry as they are too busy.

.  I am a chronic pain patient who has been on opioids since 2008.  I have degenerative disc disease.  I weakened my spine doing rigorous landscaping on a long trunk, I subsequently damaged it worse during an active sporting event.  I have had three back surgeries to remove disc material and one fusion.  I have permanent awful sciatica from permanent nerve damage & granulation tissue. 

 

I need help.  Back in October, I literally lost my job because my prescription was not delivered on time.  They are trying and being successful at making me wait till day 28 of a 28 day script.  I have always picked up on day 27 and in the past 3 years, and way back it was 5 days day 24.  Laws in federal and new york coincide to 5 days but pharmacy has own illegal policy?  Lost my job in october because of this hold, then when it was my day for them, they couldn’t get my medicine in stock within 48 hours, subsequently ran put within 12 hrs, had pain and pain anxiety resulting in issue at work and termination the following Monday.

  Complained to CVS and US Justice department to a person actually arguing what happened at CVS corporate.  Us justice dismissed my inquiry as they are too busy. 

I am at a loss Steve.  I moved here for that job and loved it.  Am now out over 20,000 dollars since this winter, cant find work in my field, going broke.   There is a bullseye on my back!

 

I used to take 3-30mg OC oxycontins per day with 4 by 10s/325 perks. That was 2010/2011 around surgeries.  Doctor has reduced to 15mg oxycodone IR x4 with muscle relaxants.  I need more but the doc wont move because I am at 90MME.  He will not even give me one dose per day!  There is money involved here and I am getting royally shafted. 

 

Nys law is not clear; says pharmacists can refuse but must pass on to guarantee care.  They cannot interfere or obstruct patients access to their medicine, yet it happened to me last month.  I dropped off, requested Saturday as it was reasonable at 2 days, promised by pharmacist herself.  Saturday came, different pharmacist said 6:45am while in pain and extremely low, “im not filling that, too early, come back tomorrow”. I had literally one tablet left.  My doctor gives 4 oxy ir per day, i was taken off the extended oxycontin because the new formula is junk, messed me up and literally caused holes in small bowel because glue/polymers.   Oxy ir works great with little side effect but i cant get 6 hours.  5 hrs okay most times and i always take it within label rate not more than 1 tablet per 4 hours.  Its a damm struggle to make each month and my doctor has a hard on for CDC recommendations.  Literally his child could be dying, he wont lift his hand an inch.  Totally brainwashed by GOV.   Its about doctor license 1st everyday of the year.

 

I’m sick of this crap, i need a friend and attorney and don’t see an absolute in law code.

AG Session: The Department of Justice under my watch is committed to transparency and the rule of law

I just made the post above a couple of days ago… apparently those within the DOJ didn’t get the memo from AG Session about the DOJ being committed to the “rule of law”. Perhaps AG Session is just using  “committed to transparency and the rule of law”  as just a good sounding “sound bite” and there is really no substance to it for the DOJ. Just more political BULL SHIT ? 🙁

 

AG Session: The Department of Justice under my watch is committed to transparency and the rule of law

DOJ to release Fast and Furious details Holder kept hidden

http://www.wnd.com/2018/03/doj-to-release-fast-and-furious-details-holder-kept-hidden/

Attorney General Jeff Sessions announced Wednesday that documents related to the failed Fast and Furious federal gun-running program that former Attorney General Eric Holder kept hidden are going to be released.

Katie Pavlich at Townhall noted Holder was voted “in civil and criminal contempt of Congress” for his actions.

Obama invoked executive privilege in June 2012 to prevent the release of the documents after the courts had said they could be publicized.

The DOJ said Wednesday the documents will be turned over to the House Oversight Committee.

“The Department of Justice under my watch is committed to transparency and the rule of law.

This settlement agreement is an important step to make sure that the public finally receives all the facts related to Operation Fast and Furious,” Sessions announced.

The release is part of the settlement of a federal case that stemmed from the Obama administration’s refusal to share the information with Congress.

The Fast and Furious plan was to allow highly specialized weapons to be sold so they could be traced to Mexican drug-cartel leaders.

 

But the Obama administration lost track of many of the weapons, and some were used in murders, including the slaying of Border Patrol Agent Brian Terry.

In a Fox News interview, Terry’s brother called on the Trump administration to reopen the investigation into the operation and to release previously withheld documents.

“We need to find out the truth, exactly what happened, how it happened, why it happened. We need Mr. Trump, President Trump, to unseal the documents, reverse executive privilege so that we know what happened, and that we can hold the people accountable that are responsible,” Kent Terry said.

Brian Terry died at the hands of Mexican cartel members in December 2010. They were carrying guns illegally trafficked by ATF to Mexico through the Fast and Furious program.

The operation trafficked “thousands of AK-47s,” as well as .50 caliber rifles.

WND reported two years ago that the failed sting operation was linked to an additional 69 deaths, including a massacre in which 22 died, in addition to the 200 deaths in Mexico alone that were reported in previous years.

I made this post… not because of the context of it..but.. because AG Session keeps talking about “the rule of law” under his watch. There a increasing number of insurance companies, PBM’s, healthcare corporations that are putting things in place that will end up with discriminating against the care that those in the chronic pain community will receive.

How to File an ADA Complaint with the U.S. Department of Justice

If AG Session  is so committed to “the rule of law” then this agency under the Dept of Justice should start taking – and acting on – complaints of discrimination from the chronic pain community SERIOUSLY..  Doesn’t make any difference if it is the DEA, CDC, FDA, CMS, HHS, state legislatures, insurance companies, PBM’s, healthcare corporations if his DOJ is going to enforce all laws equally… then let’s see if he will keep his word. or he is just using this “sound bite” to make  point about a particular issue that he feels warrants to be enforced ?

To date, most of what I have heard is that this part of DOJ … doesn’t have the resources…  Perhaps as more and more chronic painers file their complaints and take those “not enough resources” to the media. Our government can spend 81 billion/yr to fight the war on drugs… but… doesn’t have the resources to protect millions and millions of citizens who are being discriminated against by our own government ?

 

What the JAMA Opioid Study Didn’t Find

www.painnewsnetwork.org/stories/2018/3/10/what-the-krebs-opioid-study-didnt-find

A recent opioid study published in the Journal Of the American Medical Association (JAMA)  evaluated pain management in patients with hip and knee osteoarthritis and low back pain.

The study by VA researcher Erin Krebs, MD, and colleagues found that “treatment with opioids was not superior to treatment with nonopioid medications for improving pain-related function over 12 months.”  

That finding was widely and erroneously reported in the news media as meaning that opioids are ineffective for all types of chronic pain.

bigstock-Chronic-Pain--Medical-Concept-89339426.jpg

But the most fascinating result of the study – the one not being reported — is what wasn’t found. The 108 people in the study who took opioids for a year did not develop signs of opioid misuse, abuse or addiction, and did not develop opioid-induced hyperalgesia – a heightened sensitivity to pain.

And no one died of an overdose.

This is significant because it runs counter to commonly held beliefs in the medical profession about the risks of prescription opioids. Here are a few recent examples:

“Opioids are very addictive and their effectiveness wanes as people habituate to the medication,” Carl Noe, MD, director of a pain clinic at the University of Texas Medical Center wrote in an op/ed in The Texas Tribune.

Don Teater, MD, a family physician in North Carolina, also believes that people on long-term opioid therapy experience dose escalation, which leads to hyperalgesia. “Opioids cause permanent brain changes,” Teater told USA Today.

Krebs herself has made similar comments. “Within a few weeks or months of taking an opioid on a daily basis, your body gets used to that level of opioid, and you need more and more to get the same level of effect,” she told NPR.

But the Krebs study didn’t see any of that happen.

Krebs and colleagues closely monitored the 108 people in the opioid arm of the study, using “multiple approaches to evaluate for potential misuse, including medical record surveillance for evidence of ‘doctor-shopping’ (seeking medication from multiple physicians), diversion, substance use disorder, or death.” They also had participants complete the “Addiction Behavior Checklist” and assessed their alcohol and drug use with surveys and screening tools.

What did Krebs find in the opioid group after 12 months of treatment?

“No deaths, ‘doctor-shopping,’ diversion, or opioid use disorder diagnoses were detected,” she reported. “There were no significant differences in adverse outcomes or potential misuse measures.”

Health-related quality of life and mental health in the opioid group did not significantly differ from the non-opioid group – and their anxiety levels actually improved.  

These are observational findings in the study. They were not a part of what Krebs and colleagues were specifically trying to measure. As the study notes: “This trial did not have sufficient statistical power to estimate rates of death, opioid use disorder, or other serious harms associated with prescribed opioids.”

 ERIN KREBS, MD

ERIN KREBS, MD

But they are valuable observations. They note what didn’t happen in the study. Over 100 people were put on opioid therapy for a year, and none of them showed any signs of dose escalation or opioid-induced hyperalgesia, or any evidence of opioid misuse, abuse or addiction.

Krebs told the Minneapolis Star Tribune that this “could reflect the fact that the study did not enroll patients with addiction histories, and because the VA provided close supervision to all participants during the yearlong study.”

In other words, Krebs and colleagues used an opioid prescribing protocol that achieved an admirable level of patient safety. Their approach is similar to what many pain management practices currently pursue and what the CDC and various state guidelines recommend: Risk assessment before initial prescribing and careful monitoring over time.

The Krebs study provides rare and detailed observations of what happens when people are put on long-term opioid therapy. A lot of what is claimed about dose escalation, opioid-induced hyperalgesia, and misuse or abuse didn’t happen at all.

This outcome demonstrates that long-term opioid therapy can be safe and effective, and may be useful in treating other chronic conditions, from intractable neuropathies to painful genetic disorders. That’s worth reporting too, isn’t it?

 

 

 

Roger Chriss.jpg

Roger Chriss lives with Ehlers Danlos syndrome and is a proud member of the Ehlers-Danlos Society. Roger is a technical consultant in Washington state, where he specializes in mathematics and research.

The information in this column should not be considered as professional medical advice, diagnosis or treatment. It is for informational purposes only and represents the author’s opinions alone. It does not inherently express or reflect the views, opinions and/or positions of Pain News Network.

DON’T PUNISH PAIN RALLY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dear Friends and Family,

I am writing you to invite you to an event in Arizona.  Many of you know that I am an advocate on behalf of the chronic pain community.  This year, on Saturday April 7, one of our advocacy groups is planning a nationwide rally called Don’t Punish Pain.  The false information we are being fed by the media is fueling the rapid rise of overdose deaths from illegal drugs, primarily imported fentanyl (not rx fentanyl) and heroin.

In its misguided and ignorant attempt to counter what it calls the Opioid Epidemic (which it isn’t; it’s an illegal drug crisis), the government is continually stripping away the civil rights of pain patients simply because of the type of medication they need.  The result of this is more death; once a patient has been abandoned by his/her physician and cannot get help, they are left with 3 choices:  to suffer a bedridden life to an early death from pain complications, to turn to street drugs, or to commit suicide.  The attached chart will show you the results.

In spite of these useless, punitive, Draconian measures, overdose deaths are going UP all across the country.  Addicts aren’t being “saved,” but these restrictive policies are torturing pain patients who were compliant and stable in their treatment.  No one is immune; these guidelines and restrictions are affecting ANYONE in pain – and that includes cancer victims, post-operative patients, as well as palliative care and hospice patients.  Our veterans are being hit the hardest.

I am inviting you all to the Don’t Punish Pain rally of your choice. I’m attaching a document that shows which states are participating so far (we have 30), and which states still need a spokesperson.  I am the spokesperson for Arizona, so I am also attaching Arizona’s event flier.  I am also adding a form letter you can use for legislators, doctors and medical personnel, and for the media.  Doctors are another target of this opioid crackdown: they are being raided by the DEA, arrested, and attacked without cause, which are among the biggest reasons they stop prescribing life-saving medication to patients.

I am also inviting you to participate in any way you can.  This is not a march or a fund-raiser; this is a rally to bring awareness to what this crackdown on opioid prescribing is really doing to our country.  Each of us, if not already in chronic pain, is just one motor vehicle accident, one illness, one surgery away from a lifetime of chronic pain.  And while there are other therapies for pain, many are dangerous, most are not covered by insurance, and no one has developed a true replacement for opioid medication.  The rug was jerked out from under us without anything in place to catch us when our doctors’ practices are closed down by the DEA, or our doctors kick us to the curb on trumped-up charges, even to the extent of lying about the results of a urine test.

You can help by:

Spreading the word.  You can do this with letters, phone calls, social media like Facebook and Twitter, and personal emails (like this one).  Print and share the flier appropriate to your state (or states, if you like).  Take the fliers with you wherever you go, and ask permission for them to be posted.

Attending a rally of your choice.  Numbers are important, and we are also in need of able-bodied people for support.  Please note that while the nationwide rallies are being held at 12 noon EST, the Arizona rally will be at 10:00am (I forgot to account for daylight savings time).  We need your presence.

From the attached list of states, if you have friends in unrepresented states, please share this with them for encouragement.  Hopefully, someone in each of these states will be willing to step forward to lead as a spokesperson.

Please pray for me, my family, and my health.  I’m fighting chronic illness as well as chronic pain, and would dearly love your prayers for wisdom, clarity, and physical strength to see this through.  I am very blessed to have Pat at my side, helping me.

Thank you for taking the time to read this rather long letter.  If for any reason you do not want to be on this mailing list, please let me know.  I don’t want to clog your inbox with unwanted emails.

Thank you all,

Lauri